Postprandial response of bone turnover markers in patients with Crohn’s disease

Figure 4 %suppression of serum C-terminal crosslinking telopeptide of type I collagen levels at 2 h after oral glucose load in controls and in patients with Crohn’s disease active or in remission. ^aP < 0.05 vs control group; ^cP < 0.05 vs patients with active Crohn’s disease (CD). CTX: C-terminal crosslinking telopeptide of type I collagen.